APA引用形式

Conticello, C., Romano, A., Fabro, V. D., Martino, E. A., Calafiore, V., Sapienza, G., . . . Raimondo, F. D. (2019). Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network. MDPI AG.

シカゴスタイル引用形

Conticello, Concetta, et al. Feasibility, Tolerability and Efficacy of Carfilzomib in Combination With Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network. MDPI AG, 2019.

MLA引用形式

Conticello, Concetta, et al. Feasibility, Tolerability and Efficacy of Carfilzomib in Combination With Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network. MDPI AG, 2019.

警告: この引用は必ずしも正確ではありません.